NO973312D0 - Racemiseringsprosess for fremstilling av Levobupivacaine og beslektede piperidinkarboksanilid-bedövelsesmidler - Google Patents

Racemiseringsprosess for fremstilling av Levobupivacaine og beslektede piperidinkarboksanilid-bedövelsesmidler

Info

Publication number
NO973312D0
NO973312D0 NO973312A NO973312A NO973312D0 NO 973312 D0 NO973312 D0 NO 973312D0 NO 973312 A NO973312 A NO 973312A NO 973312 A NO973312 A NO 973312A NO 973312 D0 NO973312 D0 NO 973312D0
Authority
NO
Norway
Prior art keywords
levobupivacaine
anesthetics
preparation
carboxanilide
racemization process
Prior art date
Application number
NO973312A
Other languages
English (en)
Other versions
NO308843B1 (no
NO973312L (no
Inventor
Ulrich Conrad Dyer
Marianne Langston
Martin Woods
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of NO973312D0 publication Critical patent/NO973312D0/no
Publication of NO973312L publication Critical patent/NO973312L/no
Publication of NO308843B1 publication Critical patent/NO308843B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Rolling Contact Bearings (AREA)
  • Optical Head (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO973312A 1995-01-18 1997-07-17 Racemiseringsprosess for fremstilling av levobupivakain og beslektede piperidinkarboksanilid-bedøvelsesmidler NO308843B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9501071.6A GB9501071D0 (en) 1995-01-18 1995-01-18 Racemisation
PCT/GB1996/000067 WO1996022281A1 (en) 1995-01-18 1996-01-12 Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents

Publications (3)

Publication Number Publication Date
NO973312D0 true NO973312D0 (no) 1997-07-17
NO973312L NO973312L (no) 1997-07-17
NO308843B1 NO308843B1 (no) 2000-11-06

Family

ID=10768271

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973312A NO308843B1 (no) 1995-01-18 1997-07-17 Racemiseringsprosess for fremstilling av levobupivakain og beslektede piperidinkarboksanilid-bedøvelsesmidler

Country Status (20)

Country Link
EP (1) EP0804417B1 (no)
JP (1) JP4015696B2 (no)
KR (1) KR100404390B1 (no)
CN (1) CN1172912C (no)
AT (1) ATE242214T1 (no)
AU (1) AU701221B2 (no)
BR (1) BR9606821A (no)
CA (1) CA2208522C (no)
DE (1) DE69628540T2 (no)
DK (1) DK0804417T3 (no)
ES (1) ES2201166T3 (no)
FI (1) FI117437B (no)
GB (1) GB9501071D0 (no)
HU (1) HU227426B1 (no)
MX (1) MX9705428A (no)
NO (1) NO308843B1 (no)
PL (1) PL184091B1 (no)
PT (1) PT804417E (no)
WO (1) WO1996022281A1 (no)
ZA (1) ZA96403B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0002246A (pt) 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ATE482695T1 (de) 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
SI2415484T1 (sl) 2004-09-17 2014-10-30 Durect Corporation Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
JP2011506319A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
AU2014233453A1 (en) 2013-03-15 2015-10-01 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US12274794B2 (en) 2016-07-06 2025-04-15 Orient Pharma Co., Ltd. Oral dosage form with drug composition, barrier layer and drug layer
CN106187864B (zh) * 2016-07-11 2018-11-23 江苏天和制药有限公司 一种由盐酸布比卡因制备高纯度布比卡因碱的方法
JP2023515918A (ja) 2020-01-13 2023-04-17 デュレクト コーポレーション 不純物が低減された徐放性薬物送達システム及び関連の方法
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods
WO2023158722A2 (en) * 2022-02-16 2023-08-24 Teva Pharmaceuticals International Gmbh Processes for preparation of avacopan and intermediates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2301498A1 (fr) * 1975-02-20 1976-09-17 Maggioni & C Spa Methode pour la racemisation d'une lysine optiquement active

Also Published As

Publication number Publication date
DE69628540T2 (de) 2004-01-08
PL321378A1 (en) 1997-12-08
NO308843B1 (no) 2000-11-06
FI117437B (fi) 2006-10-13
MX9705428A (es) 1997-11-29
HU227426B1 (en) 2011-05-30
ZA96403B (en) 1997-01-20
AU4394896A (en) 1996-08-07
DE69628540D1 (de) 2003-07-10
HUP9901418A2 (hu) 1999-08-30
EP0804417A1 (en) 1997-11-05
NO973312L (no) 1997-07-17
CA2208522A1 (en) 1996-07-25
ES2201166T3 (es) 2004-03-16
ATE242214T1 (de) 2003-06-15
DK0804417T3 (da) 2003-10-06
CA2208522C (en) 2007-03-13
BR9606821A (pt) 1997-12-23
WO1996022281A1 (en) 1996-07-25
KR19980701432A (ko) 1998-05-15
CN1172912C (zh) 2004-10-27
AU701221B2 (en) 1999-01-21
GB9501071D0 (en) 1995-03-08
HUP9901418A3 (en) 2001-01-29
FI973040A0 (fi) 1997-07-17
JP4015696B2 (ja) 2007-11-28
PT804417E (pt) 2003-09-30
CN1168134A (zh) 1997-12-17
KR100404390B1 (ko) 2004-01-31
PL184091B1 (pl) 2002-08-30
EP0804417B1 (en) 2003-06-04
JPH11501905A (ja) 1999-02-16
FI973040L (fi) 1997-07-17

Similar Documents

Publication Publication Date Title
NO973312L (no) Racemiseringsprosess for fremstilling av Levobupivacaine og beslektede piperidinkarboksanilid-bedövelsesmidler
UA32566C2 (uk) Спосіб одержання штаму мікроорганізму, спосіб продукування триптофану
DE69637726D1 (de) Gruppen zum einfangen von nukleinsäuren
DE69629670D1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
RU93057733A (ru) Способ стереоселективного получения замещенных пиперидинов
NO314725B1 (no) N-substituerte indol-3-glyoksylamider, deres fremstilling, anvendelse for fremstilling av medikamenter, legemidler inneholdende disse samt enfremgangsmåtefor fremstilling av et legemiddel
DE69531624D1 (de) Verfahren zur herstellung von levobupivacaine und analoge
DE69942068D1 (de) Erzeugen eines nichtlinearen modells und erzeugen tzung desselben
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
YU48698A (sh) Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze
DE69525950D1 (de) Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen
HUT77631A (hu) Eljárás a levobupivakain és származékai rezolválására
ATE259369T1 (de) Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen
NO304828B1 (no) Nye cykliske aminosyrer og derivater derav, fremgangsmÕte til deres fremstilling samt mellomprodukt
ATE194602T1 (de) Verfahren zur herstellung von 1,4,7,10- tetraazacyclododecan und dessen derivaten
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer
ES2138734T3 (es) Procedimiento para la preparacion de derivados de 1-(3-trialquilsililfenil)-2,2,2-trifluormetil etanona.
NO975961L (no) Fremgangsmåte for fremstilling av 1-(3-trialkylsilylfenyl)-2,2,2-trifluorometyl-ethanonderivater
NO20023386L (no) Pseudopolymorf av (-)-cis-2-(2-Klorfenyl)-5,7-dihydroksy-8(4R- (3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-one
DE59803029D1 (de) Verfahren zur herstellung von 2-halogenindan-1-onen
DE69627184D1 (de) 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften
PL325421A1 (en) Derivatives of 4-(cycloalkyl) piperidines and 4-(cycloalkylallyl) piperidines, method for obtaining them and their therapeutic application
ATE163924T1 (de) Vorübergehend inaktiviertes benzoylperoxid, verfahren zu seiner herstellung und seine verwendung
ATE256689T1 (de) Verfahren zur herstellung von ascorbinsaüre-2- monophosphat salz
DK0819117T3 (da) Dimethylaminbenzoat- eller -p-anisatkatalyseret fremgangsmåde til fremstilling af 4-(nitrophenyl)dihydropyridiner

Legal Events

Date Code Title Description
MK1K Patent expired